Pathway-Based Analysis of a Melanoma Genome-Wide Association Study: Analysis of Genes Related to Tumour-Immunosuppression
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathway-Based Analysis of a Melanoma Genome-Wide Association Study: Analysis of Genes Related to Tumour-Immunosuppression
Authors
Keywords
Melanomas, Genome-wide association studies, Molecular genetics, Genomics statistics, Permutation, Immune suppression, T cells, Immunosuppressives
Journal
PLoS One
Volume 6, Issue 12, Pages e29451
Publisher
Public Library of Science (PLoS)
Online
2011-12-28
DOI
10.1371/journal.pone.0029451
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide association study identifies three new melanoma susceptibility loci
- (2011) Jennifer H Barrett et al. NATURE GENETICS
- Insights into Colon Cancer Etiology via a Regularized Approach to Gene Set Analysis of GWAS Data
- (2010) Lin S. Chen et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pathway Analysis of Breast Cancer Genome-Wide Association Study Highlights Three Pathways and One Canonical Signaling Cascade
- (2010) Idan Menashe et al. CANCER RESEARCH
- Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma
- (2010) Sanjiv S. Agarwala MELANOMA RESEARCH
- GSA-SNP: a general approach for gene set analysis of polymorphisms
- (2010) Dougu Nam et al. NUCLEIC ACIDS RESEARCH
- Gene Ontology Analysis of GWA Study Data Sets Provides Insights into the Biology of Bipolar Disorder
- (2009) Peter Holmans et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease
- (2009) Kai Wang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
- (2009) Marna G. Bouwhuis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- Gene and pathway-based second-wave analysis of genome-wide association studies
- (2009) Gang Peng et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case–control study
- (2009) N Schoof et al. GENES AND IMMUNITY
- Tolerogenic dendritic cells in cancer, transplantation, and autoimmune diseases
- (2009) Nicole Suciu-Foca et al. HUMAN IMMUNOLOGY
- Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls
- (2009) Y.-m. Chang et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
- (2009) Pierre Vereecken et al. MELANOMA RESEARCH
- Genome-wide association study identifies three loci associated with melanoma risk
- (2009) D Timothy Bishop et al. NATURE GENETICS
- Genomewide Association Studies and Human Disease
- (2009) John Hardy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases
- (2009) Hariklia Eleftherohorinou et al. PLoS One
- On the utility of gene set methods in genomewide association studies of quantitative traits
- (2008) Daniel I. Chasman GENETIC EPIDEMIOLOGY
- Pathway analysis of seven common diseases assessed by genome-wide association
- (2008) Ali Torkamani et al. GENOMICS
- Novel MITF targets identified using a two-step DNA microarray strategy
- (2008) Keith S. Hoek et al. Pigment Cell & Melanoma Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started